(CSNDX) iShares NASDAQ 100 USD - Ratings and Ratios
US, Large-Cap, Growth, Stocks
Description: CSNDX iShares NASDAQ 100 USD
The iShares NASDAQ100 UCITS ETF USD (Acc) (SW:CSNDX) is a US Large-Cap Growth Equity ETF listed in Switzerland, tracking the Morningstar US LM Brd Growth NR USD Index. As a fund that focuses on large-cap growth stocks in the US market, it is likely to be heavily weighted in technology and other growth-oriented sectors.
Given its underlying index, the ETF is expected to have a significant allocation to the NASDAQ-100 Index constituents, which are predominantly US technology and growth companies. This implies that the funds performance will be closely tied to the fortunes of these companies, making it a potentially attractive option for investors seeking exposure to the US technology and growth sectors.
Analyzing the
Combining the technical analysis with the
Based on the analysis, a potential trading strategy could be to buy the ETF on dips towards the 20-day SMA (1213.90) and hold it with a target price of 1300, anticipating further growth driven by the underlying trend and investor demand. However, a stop-loss should be set below the 50-day SMA (1138.70) to limit potential losses in case of a trend reversal.
Additional Sources for CSNDX ETF
CSNDX ETF Overview
Market Cap in USD | 15,910m |
Category | US Large-Cap Growth Equity |
TER | 0.30% |
IPO / Inception | 2010-01-26 |
CSNDX ETF Ratings
Growth Rating | 68.3 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | 0.26 |
Analysts | - |
Fair Price Momentum | 1223.24 USD |
Fair Price DCF | - |
CSNDX Dividends
Currently no dividends paidCSNDX Growth Ratios
Growth Correlation 3m | 95% |
Growth Correlation 12m | 43.2% |
Growth Correlation 5y | 74.9% |
CAGR 5y | 16.91% |
CAGR/Max DD 5y | 0.48 |
Sharpe Ratio 12m | 2.21 |
Alpha | 0.11 |
Beta | 1.061 |
Volatility | 16.11% |
Current Volume | 2.4k |
Average Volume 20d | 2.8k |
As of July 03, 2025, the stock is trading at USD 1296.20 with a total of 2,389 shares traded.
Over the past week, the price has changed by +1.82%, over one month by +6.14%, over three months by +16.00% and over the past year by +14.04%.
Yes. Based on ValueRay's Analyses, iShares NASDAQ 100 USD (SW:CSNDX) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 68.34 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CSNDX is around 1223.24 USD . This means that CSNDX is currently overvalued and has a potential downside of -5.63%.
iShares NASDAQ 100 USD has no consensus analysts rating.
According to our own proprietary Forecast Model, CSNDX iShares NASDAQ 100 USD will be worth about 1441.6 in July 2026. The stock is currently trading at 1296.20. This means that the stock has a potential upside of +11.22%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 1441.6 | 11.2% |